Current development of COVID-19 diagnostics, vaccines and therapeutics

A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Naru, Li, Chaoqun, Hu, Yue, Li, Kangchen, Liang, Jintian, Wang, Lili, Du, Lanying, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200352/
https://www.ncbi.nlm.nih.gov/pubmed/32387332
http://dx.doi.org/10.1016/j.micinf.2020.05.001
_version_ 1783529315210625024
author Zhang, Naru
Li, Chaoqun
Hu, Yue
Li, Kangchen
Liang, Jintian
Wang, Lili
Du, Lanying
Jiang, Shibo
author_facet Zhang, Naru
Li, Chaoqun
Hu, Yue
Li, Kangchen
Liang, Jintian
Wang, Lili
Du, Lanying
Jiang, Shibo
author_sort Zhang, Naru
collection PubMed
description A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-7200352
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Institut Pasteur. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-72003522020-05-06 Current development of COVID-19 diagnostics, vaccines and therapeutics Zhang, Naru Li, Chaoqun Hu, Yue Li, Kangchen Liang, Jintian Wang, Lili Du, Lanying Jiang, Shibo Microbes Infect Article A novel coronavirus, designated as SARS-CoV-2, first emerged in Wuhan City, Hubei Province, China, in late December 2019. The rapidly increasing number of cases has caused worldwide panic. In this review, we describe some currently applied diagnostic approaches, as well as therapeutics and vaccines, to prevent, treat and control further outbreaks of SARS-CoV-2 infection. Institut Pasteur. Published by Elsevier Masson SAS. 2020 2020-05-06 /pmc/articles/PMC7200352/ /pubmed/32387332 http://dx.doi.org/10.1016/j.micinf.2020.05.001 Text en © 2020 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhang, Naru
Li, Chaoqun
Hu, Yue
Li, Kangchen
Liang, Jintian
Wang, Lili
Du, Lanying
Jiang, Shibo
Current development of COVID-19 diagnostics, vaccines and therapeutics
title Current development of COVID-19 diagnostics, vaccines and therapeutics
title_full Current development of COVID-19 diagnostics, vaccines and therapeutics
title_fullStr Current development of COVID-19 diagnostics, vaccines and therapeutics
title_full_unstemmed Current development of COVID-19 diagnostics, vaccines and therapeutics
title_short Current development of COVID-19 diagnostics, vaccines and therapeutics
title_sort current development of covid-19 diagnostics, vaccines and therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200352/
https://www.ncbi.nlm.nih.gov/pubmed/32387332
http://dx.doi.org/10.1016/j.micinf.2020.05.001
work_keys_str_mv AT zhangnaru currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT lichaoqun currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT huyue currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT likangchen currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT liangjintian currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT wanglili currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT dulanying currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics
AT jiangshibo currentdevelopmentofcovid19diagnosticsvaccinesandtherapeutics

Ejemplares similares